ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
0.115
0.005
(4.55%)
Closed March 09 4:00PM

Telo Genomics Corporation Financial Summary

The current TELO market cap is 8.57M. The company's latest EPS is CAD -0.0364 and P/E is -3.02.

Year End June 29 2024 20202021202220232024
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -1.31M-1.26M-2.11M-2.82M-2.72M
Net Income -1.24M-1.07M-2.11M-2.82M-2.71M
Year End June 29 2024 20202021202220232024
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 1.17M3.84M2.83M2.93M965k
Total Liabilities 393k154k230k313k375k
Total Equity 775k3.69M2.6M2.61M590k

Cash Flow

Year End June 29 2024 20202021202220232024
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -1.12M-1.11M-1.8M-2.63M-2.46M
Investing -8k-9k-25k-69k-5k
Financing 2.03M3.83M876k2.68M587k
Market Cap 8.57M
Price to Earnings Ratio -3.02
Price to Sales Ratio 0
Price to Cash Ratio 10.28
Price to Book Ratio 13.9
Dividend Yield -

Share Statistics

Shares Outstanding 74.56M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.03 (19.23%)

Company Info

Company Name Telo Genomics Corporation
Address 1200-750 west pender st
vancouver, british columbia V6C 2T8
Website https://www.telodx.com
Industry blank checks (6770)

Your Recent History

Delayed Upgrade Clock